These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36554293)
1. Emotional Recognition and Its Relation to Cognition, Mood and Fatigue in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis. Argento O; Piacentini C; Bossa M; Nocentini U Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554293 [TBL] [Abstract][Full Text] [Related]
2. Relapsing-remitting and secondary-progressive multiple sclerosis patients differ in decoding others' emotions by their eyes. Argento O; Spanò B; Serra L; Incerti CC; Bozzali M; Caltagirone C; Francia A; Fratino M; Nocentini U; Piacentini C; Quartuccio ME; Pisani V Eur J Neurol; 2022 Feb; 29(2):505-514. PubMed ID: 34687120 [TBL] [Abstract][Full Text] [Related]
3. The relationship between alexithymia, reading the mind in the eyes and cognition in patients with multiple sclerosis. Karpuz Seren B; Acikgoz M; Piri Cinar B; Aciman Demirel E; Celebi U; Atasoy HT Mult Scler Relat Disord; 2022 Dec; 68():104196. PubMed ID: 36223703 [TBL] [Abstract][Full Text] [Related]
4. Theory of mind, emotion recognition and emotional reactivity factors in early multiple sclerosis: Results from a South American cohort. Crivelli L; Calandri IL; Helou B; Corvalán N; Fiol MP; Ysraelit MC; Gaitan MI; Negrotto L; Farez MF; Allegri RF; Correale J Appl Neuropsychol Adult; 2024; 31(2):162-172. PubMed ID: 34807785 [TBL] [Abstract][Full Text] [Related]
5. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970 [TBL] [Abstract][Full Text] [Related]
6. Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis. Genova HM; Lancaster K; Lengenfelder J; Bober CP; DeLuca J; Chiaravalloti ND J Neuropsychol; 2020 Jun; 14(2):213-225. PubMed ID: 31152634 [TBL] [Abstract][Full Text] [Related]
7. Theory of mind in multiple sclerosis: A neuropsychological and MRI study. Chalah MA; Kauv P; Lefaucheur JP; Hodel J; Créange A; Ayache SS Neurosci Lett; 2017 Sep; 658():108-113. PubMed ID: 28855125 [TBL] [Abstract][Full Text] [Related]
8. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis. Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673 [TBL] [Abstract][Full Text] [Related]
9. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes. Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885 [TBL] [Abstract][Full Text] [Related]
10. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions. Ciampi E; Uribe-San-Martin R; Vásquez M; Ruiz-Tagle A; Labbe T; Cruz JP; Lillo P; Slachevsky A; Reyes D; Reyes A; Cárcamo-Rodríguez C Mult Scler Relat Disord; 2018 Feb; 20():122-128. PubMed ID: 29414284 [TBL] [Abstract][Full Text] [Related]
11. Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis. Preziosa P; Rocca MA; Pagani E; Valsasina P; Amato MP; Brichetto G; Bruschi N; Chataway J; Chiaravalloti ND; Cutter G; Dalgas U; DeLuca J; Farrell R; Feys P; Freeman J; Inglese M; Meani A; Meza C; Motl RW; Salter A; Sandroff BM; Feinstein A; Filippi M; J Neurol; 2023 Mar; 270(3):1543-1563. PubMed ID: 36436069 [TBL] [Abstract][Full Text] [Related]
12. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. Dulau C; Deloire M; Diaz H; Saubusse A; Charre-Morin J; Prouteau A; Brochet B J Neurol; 2017 Apr; 264(4):740-748. PubMed ID: 28220288 [TBL] [Abstract][Full Text] [Related]
13. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage. Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004 [TBL] [Abstract][Full Text] [Related]
14. Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment. Renner A; Baetge SJ; Filser M; Penner IK Mult Scler Relat Disord; 2020 Nov; 46():102559. PubMed ID: 33035965 [TBL] [Abstract][Full Text] [Related]
15. Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis. Roca M; Manes F; Gleichgerrcht E; Ibáñez A; González de Toledo ME; Marenco V; Bruno D; Torralva T; Sinay V Cogn Behav Neurol; 2014 Mar; 27(1):25-30. PubMed ID: 24674963 [TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related]
17. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Sandi D; Rudisch T; Füvesi J; Fricska-Nagy Z; Huszka H; Biernacki T; Langdon DW; Langane É; Vécsei L; Bencsik K Mult Scler Relat Disord; 2015 Nov; 4(6):499-504. PubMed ID: 26590654 [TBL] [Abstract][Full Text] [Related]
18. Structural and cognitive correlates of fatigue in progressive multiple sclerosis. Andreasen AK; Iversen P; Marstrand L; Siersma V; Siebner HR; Sellebjerg F Neurol Res; 2019 Feb; 41(2):168-176. PubMed ID: 30513278 [TBL] [Abstract][Full Text] [Related]
19. Social Cognition in Individuals with Progressive Multiple Sclerosis: A Pilot Study Using TASIT-S. Genova HM; McDonald S J Int Neuropsychol Soc; 2020 May; 26(5):539-544. PubMed ID: 31948498 [TBL] [Abstract][Full Text] [Related]
20. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS. Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]